跳至主要内容
临床试验/NCT05000918
NCT05000918已完成不适用

Functional Food Application of Okara Protein Hydrolysate (OPH)- for Anti-exercise-fatigue

Chung Shan Medical University1 个研究点 分布在 1 个国家目标入组 18 人开始时间: 2020年7月17日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
18
试验地点
1
主要终点
Change the metabolic substances level after intervention

研究概览

简要总结

The aim of this study is to investigate the anti-exercise-fatigue effects of okara protein hydrolysate (OPH) in men

详细描述

Each subject must undergo a cardiopulmonary capacity test to assess the maximum oxygen uptake 1 week before the intervention (day 1), and then eat the test food for 4 weeks (day 8 to day 35). Before and after the intervention (the 8th and 35th day), posture measurement, diet questionnaire survey and endurance exercise ability test were carried out. The trial period was 35 days. The subjects will take blood samples before, during, after, and 30 minutes and 60 minutes after the end of the two endurance exercise tests. During the whole period of participating in the program, blood will be collected 10 times, each with a blood volume of 15 mL. Gas is collected during the period and within 1 hour after exercise. Gas is collected every 15 minutes and 1 minute at a time. Analyze his exercise time, oxygen intake and blood biochemical value.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Prevention
盲法
None

入排标准

年龄范围
20 Years 至 40 Years(Adult)
性别
Male
接受健康志愿者
是

入选标准

  • •The subject is a male and aged 20-
  • •The subject has a usual exercise habit (exercising 2 times or more per week) and did not participate in professional sports competitions or professional sports training during the study period.
  • •No smoking or drinking habits.
  • •No food allergies and the liver function is normal.
  • •No cardiovascular diseases or other chronic diseases, and no serious illnesses requiring hospitalization during the study period.
  • •The subject can understand the test process described in the consent form and the possible potential risks and benefits, and can sign the consent form.
  • •The subject can accept dietary control during the trial period.

排除标准

  • •Those who have taken nutritional supplements containing branched-chain amino acids.
  • •Those who cannot complete the endurance exercise ability test.
  • •Those who are diagnosed with kidney disease, heart disease, or cancer and are still under active treatment.
  • •Have used other drugs, whose pharmacological effects may affect fatigue.
  • •Subjects who have systemic infections and require systemic antibiotics.

研究组 & 干预措施

OPH group

Experimental

Participants should eat a pack of OPH once a day for 28 days. The dosage of the OPH is 11.74 g/day.

干预措施: Okara protein hydrolysate (OPH) (Dietary Supplement)

结局指标

主要结局

Change the metabolic substances level after intervention

时间窗: 8th day, 35th day

Compare the difference of blood lactate, lactate dehydrogenase, and creatine kinase level after exercise between pre- and post-intervention

次要结局

  • Change the exercise time after intervention(8th day, 35th day)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验